High Risk of Early Neurological Recurrence in Symptomatic Carotid Stenosis
Background and Purpose— Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis ≥50%. Methods— One hundred sixty-three patients with symptom...
Saved in:
Published in | Stroke (1970) Vol. 40; no. 8; pp. 2727 - 2731 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Lippincott Williams & Wilkins
01.08.2009
|
Subjects | |
Online Access | Get full text |
ISSN | 0039-2499 1524-4628 1524-4628 |
DOI | 10.1161/STROKEAHA.109.548032 |
Cover
Abstract | Background and Purpose—
Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis ≥50%.
Methods—
One hundred sixty-three patients with symptomatic carotid stenosis and initial mild stroke (121) or TIA (42) were evaluated within 6 hours from onset of symptoms in a single tertiary hospital. Neurological recurrence (NR) was defined as a clearly defined new neurological event (TIA or stroke) or an increase of 4 points in the initial NIHSS. The NR rate was determined at 72 hours, 7 days, and 14 days. Disability was defined as a score of 3 to 6 on the modified Rankin scale at 14 days.
Results—
Forty-five patients (27.6%) had NR, including 6 patients with 2 episodes in different time periods: 34 (20.9%) within the first 72 hours; 11 (6.7%) between 72 hours and 7 days; and 6 (3.7%) at 14 days. Only carotid stenosis ≥70% was associated with NR; diabetes was marginally associated. At 2 weeks, 19 patients (11.7%) had disability; 14 of them experienced NR in the first 72 hours.
Conclusions—
Patients with first-ever mild stroke or TIA and symptomatic carotid stenosis are at high risk for NR, especially within the first 72 hours. Our results suggest the necessity of testing pharmacological or interventional strategies for use during the hyperacute stroke phase in these patients. |
---|---|
AbstractList | Background and Purpose—
Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis ≥50%.
Methods—
One hundred sixty-three patients with symptomatic carotid stenosis and initial mild stroke (121) or TIA (42) were evaluated within 6 hours from onset of symptoms in a single tertiary hospital. Neurological recurrence (NR) was defined as a clearly defined new neurological event (TIA or stroke) or an increase of 4 points in the initial NIHSS. The NR rate was determined at 72 hours, 7 days, and 14 days. Disability was defined as a score of 3 to 6 on the modified Rankin scale at 14 days.
Results—
Forty-five patients (27.6%) had NR, including 6 patients with 2 episodes in different time periods: 34 (20.9%) within the first 72 hours; 11 (6.7%) between 72 hours and 7 days; and 6 (3.7%) at 14 days. Only carotid stenosis ≥70% was associated with NR; diabetes was marginally associated. At 2 weeks, 19 patients (11.7%) had disability; 14 of them experienced NR in the first 72 hours.
Conclusions—
Patients with first-ever mild stroke or TIA and symptomatic carotid stenosis are at high risk for NR, especially within the first 72 hours. Our results suggest the necessity of testing pharmacological or interventional strategies for use during the hyperacute stroke phase in these patients. Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis > or =50%.BACKGROUND AND PURPOSEFew data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis > or =50%.One hundred sixty-three patients with symptomatic carotid stenosis and initial mild stroke (121) or TIA (42) were evaluated within 6 hours from onset of symptoms in a single tertiary hospital. Neurological recurrence (NR) was defined as a clearly defined new neurological event (TIA or stroke) or an increase of 4 points in the initial NIHSS. The NR rate was determined at 72 hours, 7 days, and 14 days. Disability was defined as a score of 3 to 6 on the modified Rankin scale at 14 days.METHODSOne hundred sixty-three patients with symptomatic carotid stenosis and initial mild stroke (121) or TIA (42) were evaluated within 6 hours from onset of symptoms in a single tertiary hospital. Neurological recurrence (NR) was defined as a clearly defined new neurological event (TIA or stroke) or an increase of 4 points in the initial NIHSS. The NR rate was determined at 72 hours, 7 days, and 14 days. Disability was defined as a score of 3 to 6 on the modified Rankin scale at 14 days.Forty-five patients (27.6%) had NR, including 6 patients with 2 episodes in different time periods: 34 (20.9%) within the first 72 hours; 11 (6.7%) between 72 hours and 7 days; and 6 (3.7%) at 14 days. Only carotid stenosis > or =70% was associated with NR; diabetes was marginally associated. At 2 weeks, 19 patients (11.7%) had disability; 14 of them experienced NR in the first 72 hours.RESULTSForty-five patients (27.6%) had NR, including 6 patients with 2 episodes in different time periods: 34 (20.9%) within the first 72 hours; 11 (6.7%) between 72 hours and 7 days; and 6 (3.7%) at 14 days. Only carotid stenosis > or =70% was associated with NR; diabetes was marginally associated. At 2 weeks, 19 patients (11.7%) had disability; 14 of them experienced NR in the first 72 hours.Patients with first-ever mild stroke or TIA and symptomatic carotid stenosis are at high risk for NR, especially within the first 72 hours. Our results suggest the necessity of testing pharmacological or interventional strategies for use during the hyperacute stroke phase in these patients.CONCLUSIONSPatients with first-ever mild stroke or TIA and symptomatic carotid stenosis are at high risk for NR, especially within the first 72 hours. Our results suggest the necessity of testing pharmacological or interventional strategies for use during the hyperacute stroke phase in these patients. Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with first-ever mild stroke or TIA and symptomatic carotid stenosis > or =50%. One hundred sixty-three patients with symptomatic carotid stenosis and initial mild stroke (121) or TIA (42) were evaluated within 6 hours from onset of symptoms in a single tertiary hospital. Neurological recurrence (NR) was defined as a clearly defined new neurological event (TIA or stroke) or an increase of 4 points in the initial NIHSS. The NR rate was determined at 72 hours, 7 days, and 14 days. Disability was defined as a score of 3 to 6 on the modified Rankin scale at 14 days. Forty-five patients (27.6%) had NR, including 6 patients with 2 episodes in different time periods: 34 (20.9%) within the first 72 hours; 11 (6.7%) between 72 hours and 7 days; and 6 (3.7%) at 14 days. Only carotid stenosis > or =70% was associated with NR; diabetes was marginally associated. At 2 weeks, 19 patients (11.7%) had disability; 14 of them experienced NR in the first 72 hours. Patients with first-ever mild stroke or TIA and symptomatic carotid stenosis are at high risk for NR, especially within the first 72 hours. Our results suggest the necessity of testing pharmacological or interventional strategies for use during the hyperacute stroke phase in these patients. |
Author | Roquer, Jaume Ois, Angel Cuadrado-Godia, Elisa Rodríguez-Campello, Ana Jimenez-Conde, Jordi |
Author_xml | – sequence: 1 givenname: Angel surname: Ois fullname: Ois, Angel organization: From the Servei de Neurologia, Hospital del Mar, IMAS, IMIM, Universidad Autonoma de Barcelona, Barcelona, Spain – sequence: 2 givenname: Elisa surname: Cuadrado-Godia fullname: Cuadrado-Godia, Elisa organization: From the Servei de Neurologia, Hospital del Mar, IMAS, IMIM, Universidad Autonoma de Barcelona, Barcelona, Spain – sequence: 3 givenname: Ana surname: Rodríguez-Campello fullname: Rodríguez-Campello, Ana organization: From the Servei de Neurologia, Hospital del Mar, IMAS, IMIM, Universidad Autonoma de Barcelona, Barcelona, Spain – sequence: 4 givenname: Jordi surname: Jimenez-Conde fullname: Jimenez-Conde, Jordi organization: From the Servei de Neurologia, Hospital del Mar, IMAS, IMIM, Universidad Autonoma de Barcelona, Barcelona, Spain – sequence: 5 givenname: Jaume surname: Roquer fullname: Roquer, Jaume organization: From the Servei de Neurologia, Hospital del Mar, IMAS, IMIM, Universidad Autonoma de Barcelona, Barcelona, Spain |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21782441$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19498196$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kU9P4zAQxS0Eghb4Bmjly3JL8f_Ye6uqst0FgdTC2XJtB7wkcbGTQ789Qe32wIHTSKPfm5k3bwyO29h6AK4wmmAs8M3qafl4N58uphOM1IQziSg5AiPMCSuYIPIYjBCiqiBMqTMwzvkfQohQyU_BGVZMSazECPxdhJdXuAz5DcYKzk2qt_DB9ynW8SVYU8Olt31KvrUehhauts2mi43pgoUzk2IXHFx1vo055AtwUpk6-8t9PQfPt_On2aK4f_z9Zza9LyyjZVcQpwShmHLDnaSoRE445qzDmFrpsOKe0rWiVKyF5EQR46ygpjIScSbKQXgOrndzNym-9z53ugnZ-ro2rY991qLkdHgCGcAfe7BfN97pTQqNSVv93_0A_NwDJg9eq2RaG_KBI7iUhLHPjb92nE0x5-QrbUM3_CC2XTKh1hjpz0j0IZKho_QukkHMvogPd3wn-wC8Fo31 |
CODEN | SJCCA7 |
CitedBy_id | crossref_primary_10_1111_ene_13876 crossref_primary_10_1016_j_jstrokecerebrovasdis_2017_08_008 crossref_primary_10_3171_2013_7_JNS122128 crossref_primary_10_1016_j_ejvs_2011_11_008 crossref_primary_10_1111_eci_13318 crossref_primary_10_1016_j_ejvs_2015_01_007 crossref_primary_10_33529_angio2019203 crossref_primary_10_1177_1747493015609777 crossref_primary_10_1212_WNL_0b013e31829e6f37 crossref_primary_10_1136_svn_2017_000073 crossref_primary_10_1016_j_ejvs_2014_11_004 crossref_primary_10_1136_pn_2023_003918 crossref_primary_10_1212_WNL_0000000000200525 crossref_primary_10_1024_1661_8157_a003475 crossref_primary_10_1212_WNL_0000000000001780 crossref_primary_10_1016_j_ejvs_2015_01_011 crossref_primary_10_1111_j_1468_1331_2011_03452_x crossref_primary_10_2176_nmc_oa_2016_0236 crossref_primary_10_1016_j_jvs_2024_08_014 crossref_primary_10_1016_j_surge_2010_01_006 crossref_primary_10_1016_j_jocn_2023_05_024 crossref_primary_10_1212_WNL_0000000000002354 crossref_primary_10_1007_s10143_016_0737_4 crossref_primary_10_1016_j_atherosclerosis_2011_07_114 crossref_primary_10_1186_s12883_020_01907_w crossref_primary_10_1111_ene_13017 crossref_primary_10_1007_s00234_020_02546_1 crossref_primary_10_1016_j_ejvs_2011_08_004 crossref_primary_10_3310_hta18270 crossref_primary_10_1212_WNL_0000000000004486 crossref_primary_10_1016_j_ejvs_2016_01_022 crossref_primary_10_1161_STROKEAHA_120_032410 crossref_primary_10_1177_15910199241239204 crossref_primary_10_1016_j_clineuro_2014_10_008 crossref_primary_10_1016_j_ejvs_2022_04_011 crossref_primary_10_1016_j_jvs_2022_09_018 crossref_primary_10_1007_s43678_024_00759_4 crossref_primary_10_1136_bjophthalmol_2013_304316 crossref_primary_10_1161_STR_0000000000000211 crossref_primary_10_1016_j_ejvs_2013_07_015 crossref_primary_10_1016_j_jns_2023_120578 crossref_primary_10_1007_s00772_015_0105_7 crossref_primary_10_1016_j_ejvs_2011_10_016 crossref_primary_10_1016_j_jvs_2013_08_035 crossref_primary_10_1136_neurintsurg_2015_012088 crossref_primary_10_1016_j_wneu_2018_04_199 crossref_primary_10_1007_s11886_021_01593_1 crossref_primary_10_3174_ajnr_A3144 crossref_primary_10_1515_revneuro_2024_0002 crossref_primary_10_1017_S0959259810000419 crossref_primary_10_1016_j_avsg_2022_08_018 crossref_primary_10_1016_j_ejvs_2017_06_021 crossref_primary_10_1093_neuros_nyaa096 crossref_primary_10_1016_j_jvs_2010_09_015 crossref_primary_10_1186_1471_2377_14_23 crossref_primary_10_1586_14779072_2015_1088781 crossref_primary_10_1016_j_jvs_2010_09_016 crossref_primary_10_23736_S0021_9509_24_13093_5 crossref_primary_10_1186_s13643_016_0388_0 crossref_primary_10_1016_j_clineuro_2020_105855 crossref_primary_10_1016_j_ejvs_2012_02_002 crossref_primary_10_1016_j_jstrokecerebrovasdis_2014_05_003 crossref_primary_10_1016_S1853_0028_11_70006_4 crossref_primary_10_1007_s00415_011_5909_0 crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_106182 crossref_primary_10_1016_j_ejvs_2010_10_017 crossref_primary_10_1016_j_ejvs_2014_09_006 crossref_primary_10_1016_j_jvs_2022_02_040 crossref_primary_10_1111_j_1747_4949_2012_00790_x crossref_primary_10_1016_j_amjcard_2019_05_013 crossref_primary_10_1016_j_jvs_2023_10_041 crossref_primary_10_1016_j_avsg_2024_09_041 crossref_primary_10_1016_j_jvs_2020_02_024 crossref_primary_10_1016_j_jvs_2015_02_046 crossref_primary_10_1097_SLA_0000000000002933 crossref_primary_10_1016_S0749_4041_09_79253_X crossref_primary_10_1016_j_surge_2013_09_008 crossref_primary_10_1016_j_jvs_2023_03_026 crossref_primary_10_1179_1743132813Y_0000000172 crossref_primary_10_1016_j_ejvs_2014_08_012 crossref_primary_10_1007_s11883_015_0528_3 crossref_primary_10_1016_j_ejvs_2013_08_014 crossref_primary_10_1016_S0304_5412_11_70025_7 crossref_primary_10_1155_2012_340798 crossref_primary_10_23736_S0392_9590_21_04825_2 crossref_primary_10_1016_j_avsg_2014_08_028 crossref_primary_10_1016_j_avsg_2013_08_007 crossref_primary_10_1177_2396987320932065 crossref_primary_10_1227_NEU_0000000000000261 crossref_primary_10_1016_j_ejvs_2015_07_019 crossref_primary_10_1016_j_apmr_2019_12_013 crossref_primary_10_1016_j_pcad_2022_10_002 crossref_primary_10_1016_j_jvs_2017_09_021 crossref_primary_10_1016_j_ejvs_2015_03_034 crossref_primary_10_1016_j_ejvs_2015_03_035 crossref_primary_10_1212_WNL_0b013e31822b00cf crossref_primary_10_1227_NEU_0000000000000150 crossref_primary_10_1016_j_jns_2018_02_034 crossref_primary_10_1016_j_ejvs_2018_06_036 crossref_primary_10_1017_S0317167100010210 crossref_primary_10_1016_j_ejvs_2017_06_017 crossref_primary_10_1002_ana_23553 crossref_primary_10_1093_neuros_nyy557 |
Cites_doi | 10.1161/str.25.11.7974549 10.1212/01.WNL.0000110311.09970.83 10.1001/archinte.167.22.2417 10.1161/str.29.10.2118 10.1016/S0140-6736(07)61448-2 10.1016/S1474-4422(07)70248-X 10.1016/S0140-6736(97)09292-1 10.1016/S0140-6736(03)12228-3 10.1161/strokeaha.107.505438 10.1001/jama.284.22.2901 10.1161/strokeaha.107.488833 10.1161/str.31.3.601 10.1212/01.WNL.0000170368.82460.b4 10.1016/S1474-4422(07)70250-8 10.1016/j.ejvs.2005.02.045 10.1159/000113732 10.1056/NEJM199811123392002 10.1016/S1474-4422(07)70274-0 10.1161/01.cir.0000020190.45892.75 10.1136/bmj.37991.635266.44 10.1001/archneur.62.3.393 10.1161/01.str.0000133129.58126.67 10.1002/9780470752883 10.1161/str.30.6.1208 10.1161/01.str.0000147040.20446.f6 |
ContentType | Journal Article |
Copyright | 2009 INIST-CNRS |
Copyright_xml | – notice: 2009 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/STROKEAHA.109.548032 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4628 |
EndPage | 2731 |
ExternalDocumentID | 19498196 21782441 10_1161_STROKEAHA_109_548032 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | --- .3C .55 .GJ .XZ .Z2 01R 0R~ 123 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5RE 5VS 6PF 71W 77Y 7O~ A9M AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AAQQT AARTV AASCR AASOK AAUEB AAXQO AAYEP AAYJJ AAYXX ABASU ABBUW ABDIG ABJNI ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFS ACGOD ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADGHP ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC AYCSE BAWUL BCGUY BOYCO BQLVK BS7 C45 CITATION CS3 DIK DIWNM DU5 DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B M18 N4W N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YHZ YQJ YYP ZB8 ZGI ZZMQN IQODW CGR CUY CVF ECM EIF NPM 7X8 ADKSD |
ID | FETCH-LOGICAL-c437t-2d9623135a5d83070d6d4dcd113c8d195e33b9336b685292adc63afa805467313 |
ISSN | 0039-2499 1524-4628 |
IngestDate | Mon Sep 08 08:29:51 EDT 2025 Mon Jul 21 06:01:07 EDT 2025 Mon Jul 21 09:14:33 EDT 2025 Tue Jul 01 03:03:46 EDT 2025 Thu Apr 24 23:12:24 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Arterial disease Vascular disease Carotid stenosis Stroke Nervous system diseases Prognosis Central nervous system disease Risk factor Cardiovascular disease stroke care Cerebrovascular disease Cerebral disorder |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c437t-2d9623135a5d83070d6d4dcd113c8d195e33b9336b685292adc63afa805467313 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 19498196 |
PQID | 67535242 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_67535242 pubmed_primary_19498196 pascalfrancis_primary_21782441 crossref_citationtrail_10_1161_STROKEAHA_109_548032 crossref_primary_10_1161_STROKEAHA_109_548032 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-08-01 |
PublicationDateYYYYMMDD | 2009-08-01 |
PublicationDate_xml | – month: 08 year: 2009 text: 2009-08-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Stroke (1970) |
PublicationTitleAlternate | Stroke |
PublicationYear | 2009 |
Publisher | Lippincott Williams & Wilkins |
Publisher_xml | – name: Lippincott Williams & Wilkins |
References | e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_1_2 e_1_3_2_10_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_2_2 e_1_3_2_14_2 |
References_xml | – ident: e_1_3_2_12_2 doi: 10.1161/str.25.11.7974549 – ident: e_1_3_2_8_2 doi: 10.1212/01.WNL.0000110311.09970.83 – ident: e_1_3_2_20_2 doi: 10.1001/archinte.167.22.2417 – ident: e_1_3_2_9_2 doi: 10.1161/str.29.10.2118 – ident: e_1_3_2_21_2 doi: 10.1016/S0140-6736(07)61448-2 – ident: e_1_3_2_23_2 doi: 10.1016/S1474-4422(07)70248-X – ident: e_1_3_2_2_2 doi: 10.1016/S0140-6736(97)09292-1 – ident: e_1_3_2_3_2 doi: 10.1016/S0140-6736(03)12228-3 – ident: e_1_3_2_17_2 doi: 10.1161/strokeaha.107.505438 – ident: e_1_3_2_6_2 doi: 10.1001/jama.284.22.2901 – ident: e_1_3_2_10_2 doi: 10.1161/strokeaha.107.488833 – ident: e_1_3_2_25_2 doi: 10.1161/str.31.3.601 – ident: e_1_3_2_11_2 doi: 10.1212/01.WNL.0000170368.82460.b4 – ident: e_1_3_2_24_2 doi: 10.1016/S1474-4422(07)70250-8 – ident: e_1_3_2_5_2 doi: 10.1016/j.ejvs.2005.02.045 – ident: e_1_3_2_19_2 doi: 10.1159/000113732 – ident: e_1_3_2_1_2 doi: 10.1056/NEJM199811123392002 – ident: e_1_3_2_22_2 doi: 10.1016/S1474-4422(07)70274-0 – ident: e_1_3_2_15_2 doi: 10.1161/01.cir.0000020190.45892.75 – ident: e_1_3_2_7_2 doi: 10.1136/bmj.37991.635266.44 – ident: e_1_3_2_18_2 doi: 10.1001/archneur.62.3.393 – ident: e_1_3_2_16_2 doi: 10.1161/01.str.0000133129.58126.67 – ident: e_1_3_2_14_2 doi: 10.1002/9780470752883 – ident: e_1_3_2_13_2 doi: 10.1161/str.30.6.1208 – ident: e_1_3_2_4_2 doi: 10.1161/01.str.0000147040.20446.f6 |
SSID | ssj0002385 |
Score | 2.363487 |
Snippet | Background and Purpose—
Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for... Few data are available on very early stroke recurrence evaluated within the first hours after onset of symptoms and outcome for unselected patients with... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 2727 |
SubjectTerms | Aged Aged, 80 and over Biological and medical sciences Carotid Stenosis - complications Carotid Stenosis - epidemiology Cohort Studies Female Humans Ischemic Attack, Transient - epidemiology Ischemic Attack, Transient - etiology Ischemic Attack, Transient - prevention & control Male Medical sciences Middle Aged Nervous System Diseases - epidemiology Nervous System Diseases - etiology Nervous System Diseases - prevention & control Neurology Neurosurgery Risk Factors Secondary Prevention Skull, brain, vascular surgery Stroke - epidemiology Stroke - etiology Stroke - prevention & control Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Time Factors Vascular diseases and vascular malformations of the nervous system |
Title | High Risk of Early Neurological Recurrence in Symptomatic Carotid Stenosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/19498196 https://www.proquest.com/docview/67535242 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXKkBASQnzTAcMPvE0eixM7yWMFhapoILZO2lvkxM4UsSVVkz5sv557YydNYRMfL1EVx7bkc3p9r319TMg7iJFFmEvBDJ5TDjgPmeJGMJ7DbJFGOKPjeeejr3J2GszPxNlolA-yltZNepBd33iu5H9QhXeAK56S_Qdk-0bhBfwGfOEJCMPzrzDGJI0-Ody0UsWtPmVnz1a4mG5lZItyv766XDaVlWjF23qaQu8DxmVVF_XQRz1pVtWP1vX04vBwuBDrri7u8mBtarXSK6Ur9rnSNu92elHUva0_rrTdi_94vjbXDHc6ut2eSdl_NccrBrC4KrVb0wfebi1IxH06HMwnzojygOGZ16GVtaJMjk3R0GSGVhzgd1su0ZafLI6_fZlOZhMUvjpAdTq7HjqAd3nZ4uvFQQwD84uwto10XNEdcpeH4GPh5v33jao8uC3CHauETt_f1GUrLmsb2fJgHixVDYDm9haU28OU1l1ZPCIPXZxBJ5Y0j8nIlE_IvSOXSfGUzJE7FLlDq5y23KFD7tANd2hR0gF3qOMO7bjzjJx-mi4-zJi7V4NlgR82jOsYnF7PF0roCG2-ljrQmfY8P4u0Fwvj-yn8iWUqI8FjrnQmfZWrCNx7GULF52SnrErzklDfh_DVqDTW8jBIU5kanuZShYrnWujMjInfjVWSOdF5vPvkImmDT-kl_WBjLkRiB3tMWF9raUVX_vD93hYMfSWItyPwX70xedvhkoD5xD0xVZpqXScQL0MIEkATLyxcmw4d3Lu3lrwi9zf8f012mtXavAEXtUn3Wn79BGZojFQ |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High+risk+of+early+neurological+recurrence+in+symptomatic+carotid+stenosis&rft.jtitle=Stroke+%281970%29&rft.au=Ois%2C+Angel&rft.au=Cuadrado-Godia%2C+Elisa&rft.au=Rodr%C3%ADguez-Campello%2C+Ana&rft.au=Jimenez-Conde%2C+Jordi&rft.date=2009-08-01&rft.eissn=1524-4628&rft.volume=40&rft.issue=8&rft.spage=2727&rft_id=info:doi/10.1161%2FSTROKEAHA.109.548032&rft_id=info%3Apmid%2F19498196&rft.externalDocID=19498196 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon |